• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

拓扑异构酶II作用的改变是HL - 60细胞分化的一种可能分子机制。

Alteration of topoisomerase II action is a possible molecular mechanism of HL-60 cell differentiation.

作者信息

Gieseler F, Boege F, Clark M

机构信息

Medizinische Poliklinik, University of Würzburg, Federal Republic of Germany.

出版信息

Environ Health Perspect. 1990 Aug;88:183-5. doi: 10.1289/ehp.9088183.

DOI:10.1289/ehp.9088183
PMID:2176973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1567985/
Abstract

The inhibition of differentiation and persistence of proliferation in cell transformation is probably not only caused by the mutation of single genes. An additional mechanism of transcriptional control, not only of single genes but of gene programs, is possibly the alteration of the topoisomerases. These enzymes regulate the conformation of DNA by twisting and unwinding the double strands. As has been shown previously, only the genes located in relaxed DNA areas are transcribed and, therefore, the topoisomerases can be described as a gene regulation device. We present the hypothesis that topoisomerase II action is not only altered in, but also necessary for, HL-60 granulocytic cell differentiation. Thus, alteration of topoisomerases may well be a molecular mechanism of cellular differentiation.

摘要

细胞转化过程中分化的抑制和增殖的持续可能不仅仅是由单个基因突变引起的。一种转录控制的额外机制,不仅涉及单个基因,还涉及基因程序,可能是拓扑异构酶的改变。这些酶通过扭曲和解开双链来调节DNA的构象。如先前所示,只有位于松弛DNA区域的基因才会被转录,因此,拓扑异构酶可被描述为一种基因调控装置。我们提出一个假说,即拓扑异构酶II的作用不仅在HL-60粒细胞分化过程中发生改变,而且对其分化是必要的。因此,拓扑异构酶的改变很可能是细胞分化的一种分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8848/1567985/c5b072693db7/envhper00421-0176-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8848/1567985/211c993eb694/envhper00421-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8848/1567985/c5b072693db7/envhper00421-0176-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8848/1567985/211c993eb694/envhper00421-0176-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8848/1567985/c5b072693db7/envhper00421-0176-b.jpg

相似文献

1
Alteration of topoisomerase II action is a possible molecular mechanism of HL-60 cell differentiation.拓扑异构酶II作用的改变是HL - 60细胞分化的一种可能分子机制。
Environ Health Perspect. 1990 Aug;88:183-5. doi: 10.1289/ehp.9088183.
2
Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells.佛波酯处理对人白血病细胞中药物诱导的拓扑异构酶II介导的DNA切割的影响。
Cancer Res. 1988 Dec 1;48(23):6625-33.
3
Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.在一种对米托蒽醌耐药的HL-60人白血病细胞系中,拓扑异构酶IIα基因、信使核糖核酸和亚细胞蛋白质分布的改变以及DNA拓扑异构酶IIβ酶表达的降低。
Cancer Res. 1995 Apr 15;55(8):1707-16.
4
Effect of extracellular magnesium on topoisomerase II activity and expression in human leukemia HL-60 cells.细胞外镁对人白血病HL-60细胞拓扑异构酶II活性及表达的影响。
J Cell Biochem. 2000 May;78(2):325-33. doi: 10.1002/(sici)1097-4644(20000801)78:2<325::aid-jcb14>3.0.co;2-k.
5
Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.佛波酯对HL-60人白血病细胞中拓扑异构酶II活性及基因表达的影响,这些细胞对单核细胞样分化具有不同倾向。
Cancer Res. 1990 Nov 15;50(22):7116-22.
6
[DNA fragments specifically binding in vitro with isolated nuclear matrix interact with DNA-topoisomerase II present in matrix preparations].
Dokl Akad Nauk SSSR. 1988;300(4):999-1001.
7
Characterization of the promoter of the human 5-lipoxygenase gene.
Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:1-8.
8
Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.安吖啶结构类似物对含安吖啶敏感或耐药形式拓扑异构酶II的人白血病细胞系的相对活性:计算机模拟在新药开发中的应用
Cancer Res. 1992 Jan 1;52(1):209-17.
9
Expression dynamics and functional implications of DNA topoisomerase II beta in the brain.DNA拓扑异构酶IIβ在大脑中的表达动态及功能意义
Anat Sci Int. 2006 Sep;81(3):156-63. doi: 10.1111/j.1447-073X.2006.00146.x.
10
Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.苏拉明耐药性肺纤维肉瘤细胞中拓扑异构酶I和II活性的改变。
Mol Pharmacol. 1995 May;47(5):898-906.

本文引用的文献

1
DNA topoisomerase II cleaves at specific sites in the 5' flanking region of c-fos proto-oncogenes in vitro.DNA拓扑异构酶II在体外可切割c-fos原癌基因5'侧翼区域的特定位点。
EMBO J. 1986 Sep;5(9):2257-65. doi: 10.1002/j.1460-2075.1986.tb04493.x.
2
Eukaryotic topoisomerase II. Characterization of enzyme turnover.真核生物拓扑异构酶II。酶周转的特性
J Biol Chem. 1986 Jul 25;261(21):9944-50.
3
In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogene.体内抗肿瘤药物对c-myc原癌基因中拓扑异构酶II诱导的切割位点的刺激作用。
Biochem Biophys Res Commun. 1986 May 29;137(1):154-60. doi: 10.1016/0006-291x(86)91189-7.
4
ATP inhibits nuclear and mitochondrial type I topoisomerases from human leukemia cells.三磷酸腺苷(ATP)抑制来自人类白血病细胞的细胞核和线粒体I型拓扑异构酶。
Proc Natl Acad Sci U S A. 1986 Mar;83(6):1680-4. doi: 10.1073/pnas.83.6.1680.
5
Topoisomerases in human disease.人类疾病中的拓扑异构酶。
Lancet. 1988 Mar 5;1(8584):521-4. doi: 10.1016/s0140-6736(88)91308-6.
6
Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.氮芥抗性人类细胞中DNA拓扑异构酶II活性升高。
Proc Natl Acad Sci U S A. 1987 Nov;84(21):7668-71. doi: 10.1073/pnas.84.21.7668.
7
Topoisomerase II as a target of anticancer drug action in mammalian cells.拓扑异构酶II作为哺乳动物细胞中抗癌药物作用的靶点。
NCI Monogr. 1987(4):61-71.
8
Granulocytic differentiation of HL-60 cells is not regulated by DNA de novo methylation.
Blut. 1989 Mar;58(3):159-63. doi: 10.1007/BF00320438.